Diversicare Healthcare Services Inc

Diversicare Healthcare Services — Q2 2018 Earnings Presentation

35 slides from Diversicare Healthcare Services's earnings presentation, Aug 2, 2018

  1. Slide 1: Investor Update As of June 30, 2018

    Slide 1: Investor Update As of June 30, 2018

    Nasdaq: DVCR Investor Update As of June 30, 2018

  2. Slide 2: Forward-Looking Statements

    Slide 2: Forward-Looking Statements

    Nasdaq: DVCR Forward-Looking Statements Forward-looking statements made in this presentation involve a number of risks and uncertainties, but not limited to:  the outcome of proceedings alleging violations of state or Federal  our ability to increase patients served at our renovated centers False

  3. Slide 3: Non-GAAP Information

    Slide 3: Non-GAAP Information

    Nasdaq: DVCR Non-GAAP Information This presentation contains certain non-GAAP financial measures, including, EBITDA, Adjusted EBITDA and Adjusted EBITDAR. EBITDA is a non-GAAP financial measure which consists of net (loss) income before interest, income taxes, and depreciation and amortization. Adju

  4. Slide 4: Investment Highlights

    Slide 4: Investment Highlights

    Nasdaq: DVCR Investment Highlights Leading Skilled Nursing Provider Compelling Demographic Trends Management’s Strategic Vision Yielding Results Improving Patient Quality Measures, Census And Skilled Mix Demonstrated Ability To Grow And Enhance Portfolio Positively Trending Financial Results 4

  5. Slide 5: Executive Leadership

    Slide 5: Executive Leadership

    Nasdaq: DVCR Executive Leadership Jay McKnight Leslie Campbell Chief Executive Officer Chief Operating Officer • Joined Diversicare in 2012 as CFO • Joined Diversicare in 2012 • 10+ Years of senior finance • 20+ years of experience in the LTC positions in the healthcare industry industry • Previous

  6. Slide 6: Diversicare at a Glance

    Slide 6: Diversicare at a Glance

    Nasdaq: DVCR Diversicare at a Glance 2017 Q2 Revenue $142.6M – 2018 Q2 Reported Revenue $141.1M – 2018 Q2 legacy GAAP Revenue $144.5M; 1.4% Growth Currently – 75 SNFs, 1 ALF – 8,456 Licensed Skilled Nursing Beds – 10 States Headquartered in Brentwood, TN PA IA NE OH (5) IL IN (1) CO WV KS (6) MO VA

  7. Slide 7: Company Profile

    Slide 7: Company Profile

    Nasdaq: DVCR Company Profile . Public Company since 1994 . NASDAQ Listed Company Symbol: DVCR . Added to Russell Microcap Index in 2014 . 52 week range $6.55 – $12.00 . Historically paid $0.22 annual dividend . Headquartered in Brentwood, TN 7

  8. Slide 8: Long Term Care Industry Overview

    Slide 8: Long Term Care Industry Overview

    Nasdaq: DVCR Long Term Care Industry Overview • Compelling Demographic Trends • High Quality Clinical Outcomes • Relative Low Cost of Care • Risks to the Industry and the Company 8

  9. Slide 9: Compelling Industry Demographics

    Slide 9: Compelling Industry Demographics

    Nasdaq: DVCR Compelling Industry Demographics Number of Skilled Nursing Facilities 17,000 16,500 16,000 15,500 Stable Supply Stable 15,000 2000 2002 2004 2006 2008 2010 2012 2014 2016 Age 65+ Population (in millions) 100 80 60 40 20 Rising Demand Rising 0 1990 2000 2010 2020E 2030E 2040E 2050E 2060E

  10. Slide 10: Compelling Industry Demographics

    Slide 10: Compelling Industry Demographics

    Nasdaq: DVCR Compelling Industry Demographics • Long term care spending continues to increase ‒ Medicare and Medicaid expenditures for SNFs expected to grow 57% from 2015 to 2025 ‒ Annual spending on older adults is expected to increase 250% by 2040 Medicare and Medicaid SNF Spending (in billions) 8

  11. Slide 11: Relative Cost Per Case of Treatment Across Post-Acute Care Providers

    Slide 11: Relative Cost Per Case of Treatment Across Post-Acute Care Providers

    Nasdaq: DVCR Relative Cost Per Case of Treatment Across Post-Acute Care Providers $115 $120 $100 $75 $80 $67 $60 $45 $34 $31 $40 $26 $26 $18 $17 $11 $20 $8 $9 $6 $10 $0 Stroke Hip Fracture Joint Respiratory w/ Tracheotomy w/ Replacement Vent Vent SNF IRF LTAC SNFs are recognized as high quality, low

  12. Slide 12: Risks to the Industry and the Company

    Slide 12: Risks to the Industry and the Company

    Nasdaq: DVCR Risks to the Industry and the Company A number of risks may impact the Industry in general and the Company in particular, including litigation risks and Government reimbursement/regulation risks. Litigation Risks include: • The provision of health care services results in numerous profe

  13. Slide 13: Risks to the Industry and the Company

    Slide 13: Risks to the Industry and the Company

    Nasdaq: DVCR Risks to the Industry and the Company Government Reimbursement Risks include: • In recent years, there have been initiatives on the federal and state levels for comprehensive reforms affecting the availability, payment and reimbursement of healthcare services in the United States. The I

  14. Slide 14: Company Overview

    Slide 14: Company Overview

    Nasdaq: DVCR Company Overview • Mature Company • Provides a full spectrum of post-acute healthcare services • Robust operating platform capable of significant growth expansion 14

  15. Slide 15: Key Strategic Accomplishments

    Slide 15: Key Strategic Accomplishments

    Nasdaq: DVCR Key Strategic Accomplishments Retooling: Areas of Focus Expanded Platform Operational Facility Focus Now On Development Improvement Renovations Portfolio Growth Launched Q3 2010 Today Investments made in internal improvements and scalability position Diversicare for external growth 15

  16. Slide 16: Platform Development and Operational Improvements

    Slide 16: Platform Development and Operational Improvements

    Nasdaq: DVCR Platform Development and Operational Improvements Implement an Electronic Medical Record (EMR) Solution Centralization of Key Processes People – Processes – Resources Completed – Company repositioned for rapid growth 16

  17. Slide 17: Key Results and Outcomes

    Slide 17: Key Results and Outcomes

    Nasdaq: DVCR Key Results and Outcomes • Improved Quality Measures • Improved patient mix and reimbursement rates • Improved operating and G&A leverage • Demonstrated growth through acquisitions 17

  18. Slide 18: Adoption of ASC 606

    Slide 18: Adoption of ASC 606

    Nasdaq: DVCR Adoption of ASC 606 - Effective January 1, 2018, the Company adopted the new revenue recognition standard in accordance with Accounting Standards Codification (“ASC”) 606. - The Company used the modified retrospective adoption approach. Therefore, prior year revenue was not restated and

  19. Slide 19: Results for All Centers: Star Quality Measures Relative to For-Profit Peer Group

    Slide 19: Results for All Centers: Star Quality Measures Relative to For-Profit Peer Group

    Nasdaq: DVCR Results for All Centers: 5 Star Quality Measures Relative to For-Profit Peer Group 4.4 4.17 4.2 4.0 3.8 3.6 3.4 3.2 3.0 Overall QM Rating DVCR Industry For-Profit Not-For-Profit Diversicare is an industry leader in 5 Star Quality Measures outcomes. 19

  20. Slide 20: Results: Rate Increases Driven By Higher Acuity (Medicare)

    Slide 20: Results: Rate Increases Driven By Higher Acuity (Medicare)

    Nasdaq: DVCR Results: Rate Increases Driven By Higher Acuity • Medicare rate growth driven by acuity • 17.4% Increase from FY10 Q3 to FY18 Q2 • 4.0% CAGR Medicare Rate Per Day $480 $455 A $430 $388 $380 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 '

  21. Slide 21: Results: Rate Increases Driven By Higher Acuity (Medicaid)

    Slide 21: Results: Rate Increases Driven By Higher Acuity (Medicaid)

    Nasdaq: DVCR Results: Rate Increases Driven By Higher Acuity • Medicaid rates driven by acuity • 20.1% Increase from FY10 Q3 to FY18 Q2 • 4.7% CAGR Medicaid Rate Per Day $180 $178 $175 $170 $165 $160 $148 $155 $150 $145 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

  22. Slide 22: Results: Growth in Operated Facilities

    Slide 22: Results: Growth in Operated Facilities

    Nasdaq: DVCR Results: Growth in Operated Facilities 80 76 75 70 65 60 55 50 45 45 40 35 30 2014 2014 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 • Our ability to integrate facilities onto our platform is proven

  23. Slide 23: Results: Impact Of New Centers

    Slide 23: Results: Impact Of New Centers

    Nasdaq: DVCR Results: Impact Of New Centers Acquisitions are Accretive to earnings within a quarter of acquisitions date – the exceptions being development opportunities like new construction, major renovations, etc. Demonstrated Platform Scalability by successful integration of new facilities New F

  24. Slide 24: Results: Revenue Impact of Acquisitions

    Slide 24: Results: Revenue Impact of Acquisitions

    Nasdaq: DVCR Results: Revenue Impact of Acquisitions Quarterly Revenue $160 $140 $120 $100 $80 $60 $40 $20 $- Q1 ’14 Q2 '14 Q3 '14 Q4 '14 Q1 '15 Q2 '15 Q3 '15 Q4 '15 Q1 '16 Q2 '16 Q3 '16 Q4 '16 Q1 '17 Q2 '17 Q3 '17 Q4 '17 Q1 '18 Q2 '18 Same-store group* 2015 Acquisitions (3) 2016 Acquisitions (22) 2

  25. Slide 25: Results: New Centers and Same-Store

    Slide 25: Results: New Centers and Same-Store

    Nasdaq: DVCR Results: New Centers and Same-Store *Same-Store group represents all nursing centers acquired by the Company prior to January 1, 2017. 25

  26. Slide 26: Results: Revenue Growth and Operating Leverage

    Slide 26: Results: Revenue Growth and Operating Leverage

    Nasdaq: DVCR Results: Revenue Growth and Operating Leverage • Continued Company-wide cost reduction efforts in place o Diligent vendor management and product selection criteria o Centralized purchasing functions drive consistency through all facilities o Revenue and operating expenses increased in t

  27. Slide 27: Results: G&A Leverage

    Slide 27: Results: G&A Leverage

    Nasdaq: DVCR Results: G&A Leverage • Continued G&A reduction efforts in place o Right-sized overhead structure for new portfolio o Centralized core functions to leverage skilled teams • Savings from G&A reductions funded strategic investments G&A Expense as a % of Revenue 8.0% A 7.0% B 6.0% 5.0% Q1

  28. Slide 28: Current Areas of Focus

    Slide 28: Current Areas of Focus

    Nasdaq: DVCR Current Areas of Focus • Continuous quality improvement • Enhancing existing portfolio • Growth through accretive acquisitions 28

  29. Slide 29: Continue to Enhance Existing Portfolio

    Slide 29: Continue to Enhance Existing Portfolio

    Nasdaq: DVCR Continue to Enhance Existing Portfolio Continuous improvement of Quality Measures Continue to drive volume of patients served Improve skilled mix / provide high-acuity services Ongoing renovations of existing facilities 29

  30. Slide 30: Portfolio Growth

    Slide 30: Portfolio Growth

    Nasdaq: DVCR Portfolio Growth Achieved goal of doubling the size of the Company in 3 years Target: 5-10 new facilities per year Active acquisition pipeline Expanded operating infrastructure = Scalability Structure flexibility = Several sources of financial capacity 30

  31. Slide 31: Flexible Structure Broadens Pipeline

    Slide 31: Flexible Structure Broadens Pipeline

    Nasdaq: DVCR Flexible Structure Broadens Pipeline Acquisition Types 2010 Today • Full Ownership Of Assets Fee-Simple • Participate In Value Appreciation 20% 24% Acquisitions • Enhance Facility Ownership Assumption of • Minimal Capital Required Long-Term Operating • Leverage Turnaround Capabilities 8

  32. Slide 32: Summary

    Slide 32: Summary

    Nasdaq: DVCR Summary • Improved operational and financial results • Attractive investment dynamics • Repositioned for the future 32

  33. Slide 33: Key Financial and Operating Statistics

    Slide 33: Key Financial and Operating Statistics

    Nasdaq: DVCR Key Financial and Operating Statistics Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Average Daily Census 6,746 6,756 6,740 6,854 6,749 Total Average Daily Census – 996 1,086 988 994 1,053 Medicare & Managed Care Skilled Mix % 14.8% 16.1% 14.7% 14.5% 15.6% Occupancy (Available Beds) 84.5% 84.

  34. Slide 34: Investment Highlights

    Slide 34: Investment Highlights

    Nasdaq: DVCR Investment Highlights Leading Skilled Nursing Provider Compelling Demographic Trends Management’s Strategic Vision Yielding Results Improving Patient Quality Measures, Census And Skilled Mix Demonstrated Ability To Grow And Enhance Portfolio Positively Trending Financial Results 34

  35. Slide 35: Appendix A: Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR

    Slide 35: Appendix A: Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR

    Nasdaq: DVCR Appendix A: Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR (a) Represents non-recurring costs associated with acquisition-related transactions. (b) Represents non-recurring lease termination receipts, net of expenses, related to the termination of the Carthage, Mis

Source: SEC EDGAR · 8-K filed Aug 2, 2018

More decks from Diversicare Healthcare Services Inc